<DOC>
	<DOC>NCT00370721</DOC>
	<brief_summary>To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR</brief_summary>
	<brief_title>Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Cases of active progressive PDR with history of scatter laser photocoagulation history of vitrectomy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Proliferative diabetic retinopathy(PDR)</keyword>
	<keyword>Pan retinal photocoagulation (PRP)</keyword>
	<keyword>Vitreous hemorrhage</keyword>
	<keyword>Traction retinal detachment</keyword>
	<keyword>Neovascularization on disc (NVD)</keyword>
	<keyword>Neovascularization elsewhere (NVE)</keyword>
	<keyword>Fibrous proliferation on disc (FPD)</keyword>
	<keyword>Fibrous proliferaiton elsewhere (FPE)</keyword>
</DOC>